# Meridian Bioscience completes acquisition of Exalenz Bioscience

Meridian Bioscience, Inc. completed its acquisition of Exalenz Bioscience Ltd., an Israeli provider of BreathID urea breath test systems for H. pylori detection.

- Type: Acquisition
- Announced: 2020-04-30
- Where: Modiin, Israel, Israel
- Status: completed
- Products: diagnostic testing solutions, urea breath test systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Meridian Bioscience](https://endata.com/companies/39174.md) (acquirer)
- [Exalenz Bioscience](https://endata.com/companies/46915.md) (target)

## Sources

- [biospace.com](https://www.biospace.com/meridian-bioscience-announces-closing-of-transaction-to-acquire-exalenz-bioscience), 2020-04-30: "We are excited to complete the acquisition of Exalenz Bioscience Ltd. and its H. pylori urea breath testing systems."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.